385 Views

DIABETES CANADA

CLINICAL CARE AND EDUCATION DQ

DIABETES

SIMULTANEOUS INTERPRETATION

DQ & DC JOINT SESSION (WITH DC AWARDS) / SESSION COMMUNE DE DIABÈTE QUÉBEC ET DIABETES CANADA (REMISE DE PRIX DE DIABETES CANADA)

DC/DQ CONNECTING WITH PERSONS WITH TYPE 1 DIABETES IN CANADA – BETTER CAPACITY FOR CARE (DC-027)

Thursday, October 26, 2023

16:30 – 17:30 EST

Location: Palais, 517B

Co-Chair(s)

Kaberi Dasgupta, MD, MSc (Professor of Medicine and Physician Scientist) (she/her/hers)

Professor of Medicine, Physician, Researcher
McGill University and Centre for Outcomes Research and Evaluation at the Research Institute of the McGill University Health Centre
McGill University
Peter A. Senior, MD, PhD (he/him/his)

Director
Alberta Diabetes Institute
University of Alberta

Presenter(s)

Aude Bandini (she/her/hers)

Associate Professor
Université de Montréal
Université de Montréal
Anne-Sophie Brazeau, PDt, PhD

Assistant professor
McGill University
McGill University
Linxi Mytkolli (she/her/hers)

Patient partner & Lead of patient engagement
Connect1d, Diabetes Action Canada
University of Toronto

Disclosure(s):

Peter A. Senior, MD, PhD: Bayer: Consultant/Advisory Board (Ongoing); Dexcom: Consultant/Advisory Board (Ongoing); Eli Lilly: Consultant/Advisory Board (Ongoing); Insulet: Consultant/Advisory Board (Ongoing); Novo Nordisk: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Vertex: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Anne-Sophie Brazeau, PDt, PhD: Canadian Institute for Health Research: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Dexcom: Speaker/Honoraria (Terminated, January 31, 2023); Diabète Québec: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Fonds de recherche du Québec en Santé: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Juvenile Diabetes Research Foundation: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Mitacs: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Linxi Mytkolli: No financial relationships to disclose

Learning Objectives / Objectifs d'apprentissage:

At the end of this session participants will be able to / Au terme de cette conférence, vous serez:

Discuss the importance of engaging those with lived experience in supporting clinical care and research;
Describe practical considerations for meaningful partnership with individuals living with diabetes to support clinical practice and research; and
Present initiatives co-developed with patient-partners to accelerate type 1 diabetes research, support advocacy, and disseminate knowledge in Canada.